Quantum Computing Leader IonQ Strengthens Board Retention with Stock Awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IonQ director Kathryn K. Chou received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Chou beneficially owns a total of 67,628 shares directly.
Key terms of the RSU award:
- Vesting occurs at the earlier of: - 2026 Annual Meeting (or day prior if service ends at meeting) - June 18, 2026
- Vesting is contingent on continued service as Board member
- RSUs were granted at $0 exercise price
This Form 4 filing represents a standard director equity compensation grant, likely part of IonQ's annual board member compensation package. The transaction was executed under normal circumstances with no indication of any Rule 10b5-1 trading plan involvement.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Chou Kathryn K.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,513 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 67,628 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What are the vesting terms for IONQ Director Kathryn Chou's RSU grant?
The RSUs will vest in full on the earlier of (i) the date of the 2026 Annual Meeting (or the day before if her service ends at that meeting), or (ii) June 18, 2026, subject to her continued service as a Board member through the vesting date.
Who filed the Form 4 for IONQ Director Kathryn Chou?
The Form 4 was signed by Stacey Giamalis as Attorney-in-Fact for Kathryn Chou on June 18, 2025.